albiglutide) and PIONEER-6 (oral semaglutide) [8]
Nat Rev Endocrinol 8(12):728742 Davies MJ, Bain SC, Atkin SL, Rossing P, Scott D, Shamkhalova MS et al (2015) Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial
While convenient, this means you're self-selecting without professional guidance
Treatments for behavioral and dietary health are known to improve the emotional well-being of people experiencing menopause, leading some experts to believe weight loss with GLP-1s could have similar benefits
Some researchers report that injecting on a completely empty stomach intensifies initial nausea
As a GLP-1 receptor agonist, it stimulates the pancreas to produce insulin when blood sugar is high and inhibits glucose release from the liver when levels are low helping maintain stable blood sugar levels essential for managing diabetes